Toggle Main Menu Toggle Search

Open Access padlockePrints

Construct validity of real-world digital mobility outcomes in patients after proximal femoral fracture: a cross-sectional observational study

Lookup NU author(s): Professor Lynn RochesterORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© The Author(s) 2026.Digital mobility outcomes (DMOs) offer unique insights into recovery of real-world mobility after proximal femoral fracture (PFF), but their clinical validity remains to be established. This study assessed construct validity (convergent, divergent, and known-groups) of 24 DMOs measuring walking activity (amount, pattern) and gait (pace, rhythm, bout-to-bout variability) in patients within one year after PFF. Patients were recruited from inpatient and outpatient lists at five European sites, resulting in 505 included participants (66% female), with mean age of 77.6 ± 9.4 years and supervised gait speed of 0.7 ± 0.4 m/s. Mobility was monitored over seven days using a single wearable device on the lower back. Convergent and divergent validity analyses were stratified by two groups: acute (≤ 14 days since surgery) and non-acute (≥ 15 days since surgery). Correlations between DMOs and related (clinical- and patient-reported mobility outcomes) and unrelated constructs (hearing impairment and systolic blood pressure) were compared to a priori expected correlations. Known-groups validity was assessed across four recovery phases. The results were evaluated individually by experts and in a subsequent consensus meeting, with 17 of 24 DMOs showing evidence of construct validity in non-acute PFF patients. These findings represent an initial step in a larger process towards regulatory endorsement.


Publication metadata

Author(s): Eckert T, Berge MA, Long M, de las Heras M, Alvarez P, Blain H, Braun J, Buekers J, Caulfield B, Engdal M, Frei A, Helbostad JL, Ionescu A, Jansen C-P, Johnsen LG, Klenk J, Koch S, Lanfranchi V, Rochester L, Becker C, Vereijken B, Garcia-Aymerich J

Publication type: Article

Publication status: Published

Journal: Scientific Reports

Year: 2026

Volume: 16

Issue: 1

Online publication date: 20/03/2026

Acceptance date: 03/03/2026

Date deposited: 14/04/2026

ISSN (electronic): 2045-2322

Publisher: Nature Research

URL: https://doi.org/10.1038/s41598-026-43297-y

DOI: 10.1038/s41598-026-43297-y

Data Access Statement: The data presented in this paper was generated during the IMI2 Mobilise-D project. The dataset from this project will be released under a C.C.4.0 NC license in June 2026 at https://zenodo.org/communities/mobilise-d/ according to the data release schedule agreed by the Mobilise-D consortium. Please direct any data-related queries to: Brian CaulfieldEmail: b.caulfield@ucd.ie.

PubMed id: 41862587


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Cumbria, Northumberland, and Tyne and Wear NHS Foundation Trust
CEX2023-0001290-S funded by MCIN/AEI/ https://doi.org/10.13039/501100011033
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Union Horizon 2020 research and innovation program
Generalitat de Catalunya through the CERCA Program
IMI2 JU project IDEA-FAST (grant agreement 853981)
Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No. 820820
National Institute for Health and Care Research (NIHR) Sheffield Biomedical Research Centre (NIHR203321)
Newcastle University
NIHR Newcastle Biomedical Research Centre based at The Newcastle upon Tyne Hospital National Health Service (NHS) Foundation Trust
NIHR Senior Investigator Awards (2020–2024 and 2024–2028)
NIHR/Wellcome Trust Clinical Research Facility infrastructure at Newcastle upon Tyne Hospitals NHS Foundation Trust

Share